KP

Ketan Popat

Active Director Director DIN 10671385
DIN 10671385 First appointment Jun 2024 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Jun 2024
Shareholding value Locked Premium profile

About Ketan Popat

Ketan Popat has 2 years in corporate governance. Holds Director role. Currently with 1 company, including Arpra Biotech Private Limited. Engaged in Technology. Contributes to corporate operations.

DIN 10671385
Primary Designation Director
First Appointment 26 Jun 2024
Oldest Company Age 2 yrs

Current companies

Company Designation Appointment Founded Status
Arpra Biotech Private Limited U20116DL2023PTC420283
Director 26 Jun 2024 2023 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Arpra Biotech Private Limited
Premium access

Shareholding and investment profile for Ketan Popat

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ketan Popat

Ketan Popat has 2 years in corporate governance. Holds Director role. Currently with 1 company, including Arpra Biotech Private Limited. Engaged in Technology. Contributes to corporate operations.

Ketan Popat is associated with 1 company as Director.

Ketan Popat has expertise in Technology.

Ketan Popat has 2 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available